生物经济（970038）指数十大成份股详情如下： 证券之星消息，1月26日，生物经济（970038）指数报收于2278.54点，涨0.57%，成交406.86亿元，换 手率3.97%。当日该指数成份股中，上涨的有27家，华兰疫苗以20.0%的涨幅领涨，下跌的有23家，美 好医疗以5.46%的跌幅领跌。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 资金流向方面，生物经济（970038）指数成份股当日主力资金净流入合计8.04亿元，游资资金净流入合 计8901.37万元，散户资金净流出合计8.93亿元。成份股资金流向详情见下表： ...

Core Viewpoint - The Biotech Economy Index (970038) closed at 2312.84 points, reflecting a 0.68% increase with a trading volume of 47.837 billion yuan and a turnover rate of 3.49% [1] Group 1: Index Performance - On the day, 30 constituent stocks of the Biotech Economy Index experienced gains, with Di'an Diagnostics leading the rise at 11.9% [1] - Conversely, 19 stocks declined, with Meihua Medical showing the largest drop at 6.93% [1] Group 2: Capital Flow - The net inflow of main funds into the Biotech Economy Index constituents totaled 274 million yuan, while speculative funds saw a net outflow of 85.3729 million yuan [2] - Retail investors also experienced a net outflow of 188 million yuan [2]

Group 1 - The core index of the biotechnology sector, the Biotechnology Index (970038), closed at 2297.26 points, reflecting a 1.74% increase with a trading volume of 34.699 billion yuan and a turnover rate of 2.6% [1] - Among the constituent stocks of the Biotechnology Index, 35 stocks experienced an increase, with Dean Diagnostics leading the rise at 19.98%, while 14 stocks saw a decline, with New Industry leading the drop at 3.84% [1] Group 2 - In terms of capital flow, the Biotechnology Index constituents experienced a net outflow of 190 million yuan from major funds, while retail investors saw a net inflow of 286 million yuan [2] - The detailed capital flow indicates that speculative funds had a net outflow of approximately 95.6729 million yuan [2]

Core Viewpoint - The Biotech Economy Index (970038) closed at 2120.29 points, down 0.12%, with a trading volume of 13.62 billion yuan and a turnover rate of 1.11% [1] Group 1: Index Performance - On the day, 16 stocks in the Biotech Economy Index rose, with Deep Technology leading at a 2.83% increase, while 30 stocks fell, with Dean Diagnostics leading the decline at 2.96% [1] - The net outflow of main funds from the Biotech Economy Index stocks totaled 640 million yuan, while retail investors saw a net inflow of 454 million yuan [1] Group 2: Top Constituents - The top ten constituents of the Biotech Economy Index include: - Mindray Medical (sz300760) with a weight of 12.66% and a market cap of 242.125 billion yuan [1] - Shizhu Aoshi (sz002252) with a weight of 4.95% and a market cap of 42.549 billion yuan [1] - Changchun High-tech (sz000661) with a weight of 4.56% and a market cap of 38.832 billion yuan [1] - Kanglong Chemical (sz300759) with a weight of 4.17% and a market cap of 51.585 billion yuan [1] - Taige Pharmaceutical (sz300347) with a weight of 4.10% and a market cap of 44.119 billion yuan [1] - Muyuan Foods (sz002714) with a weight of 3.87% and a market cap of 270.899 billion yuan [1] - Deep Technology (sz000021) with a weight of 3.86% and a market cap of 38.318 billion yuan [1] - Jiao Yue Medical (sz002223) with a weight of 3.22% and a market cap of 37.854 billion yuan [1] - Aimeike (sz300896) with a weight of 3.04% and a market cap of 43.694 billion yuan [1] - Watson Bio (sz300142) with a weight of 3.00% and a market cap of 17.833 billion yuan [1] Group 3: Fund Flow Details - The fund flow details indicate that Deep Technology had a main fund net inflow of 151 million yuan, while retail investors had a net outflow of 91.497 million yuan [2] - Kanglong Chemical experienced a main fund net inflow of 17.121 million yuan, with retail investors seeing a net inflow of 1.917 million yuan [2] - The Biotech Economy Index constituents underwent adjustments, adding 9 stocks and removing 9 stocks [2][3]

Core Viewpoint - The Biotech Index (970038) closed at 2259.94 points, down 0.06%, with a trading volume of 17.182 billion yuan and a turnover rate of 1.24% on October 23 [1] Group 1: Index Performance - The Biotech Index had 26 stocks rising and 22 stocks falling on the day, with Huace Testing leading the gainers at a 3.03% increase, while Jingxin Pharmaceutical led the decliners with a 4.17% drop [1] - The top ten constituent stocks of the Biotech Index include: - Mindray Medical (13.81% weight, latest price 221.80, market cap 268.92 billion yuan) [1] - Changchun High-tech (5.41% weight, latest price 117.65, market cap 47.994 billion yuan) [1] - Kanglong Chemical (4.66% weight, latest price 31.44, market cap 55.906 billion yuan) [1] - Others include Shishi Yushang, Biao Ge Pharmaceutical, and more, all within the biotech and related sectors [1] Group 2: Capital Flow - The Biotech Index constituents experienced a net outflow of 502 million yuan from main funds, while retail investors saw a net inflow of 354 million yuan [3] - Detailed capital flow for key stocks includes: - Deep Technology: Main fund net inflow of 82.5949 million yuan, retail net inflow of 21.4 million yuan [3] - Mindray Medical: Main fund net inflow of 66.9479 million yuan, retail net outflow of 3.6088 million yuan [3] - Other stocks like Muyuan Foods and Kanglong Chemical also showed varying levels of net inflow and outflow from different investor categories [3]